Check out your Company Bowl for anonymous work chats.
Evonik invests US$220 million in partnership with the U.S. Government to build new lipid production facility for mRNA-based therapies in the U.S. The new plant at Evonik’s Tippecanoe site in Lafayette, Indiana, will broadly position the Group for future growth in novel mRNA-based therapies beyond COVID-19 vaccines and strengthen its leading role as a strategic partner for innovative pharmaceutical companies worldwide.
DIVERSITY AT EVONIK Diversity creates growth, innovation and customer proximity We are convinced of the power of diversity. At Evonik, we promote an open performance culture in which all employees have equal opportunities regardless of race, ethnicity, age, religion, gender, sexual orientation or disability. We focus on transparency, networking, and support for all of our employees and, based on this, we offer a wide range of offers and measures in order to anchor diversity firmly in our corporate culture. Check out our new diversity page!
#WHYWEDOIT - STEPHAN Stephan is responsible for the global business development of environmental technologies in the Active Oxygens Business Line at Evonik. In his interview, he explains what inspires him about his job and how he works with Evonik to act more sustainably.
“It never gets boring”. As process engineer, Anika develops innovative solutions for continuously optimizing production processes at Evonik. Thank you Anika for sharing your "WhyWeDoIt - Everyone feels an inner motivation to do the things they do, whether it´s in their personal or professional life. What is it that drives you?" with us. In our #WhyWeDoIt campaign, employees tell what they like most about their work and why they do what they do every day.
Award for sustainability: Platinum rating for Evonik The EcoVadis rating agency has awarded Evonik a "platinum" rating for its sustainability performance for the first time. This puts Evonik among the top 1 percent of companies assessed by EcoVadis, both in the chemicals sector and in all other industries. In previous years, EcoVadis had already rated the specialty chemicals company "Gold" six times.
Start of production in record time: Evonik is helping to accelerate the production of the COVID-19 vaccine from Pfizer-BioNTech by suppling an essential component. Evonik is delivering first batches of the urgently needed lipids for the mRNA-based vaccine to BioNTech months earlier than planned. Specialists at Evonik’s Hanau site had set up the lipid production in just eight weeks, meeting the high-quality requirements for the component. Initially, delivery was scheduled to start in the middle of the year.
Evonik is recognized as one of the 25 best employers in the #2021-LinkedIn-Top Companies list. According to this ranking, Evonik is not only a company that is attractive for talents, but also really invests in their employees and help advance their careers. This year the respective rating considers career opportunities, skills growth, company affinity, gender diversity, sense of belonging and corporate stability.
BVB Dortmund Bus makes a stop in Lafayette, IN, to put on a clinic for children of Evonik employees. #HumanChemistry
Evonik’s Wallingford, Connecticut site recently awarded its annual Future Engineers Scholarships. Wallingford plant manager Joe Schiers (center) presented two $1,500 Future Engineers Scholarships to a graduating senior from each of the town’s two high schools. These awards are part of the Wallingford plant’s ongoing efforts to support local students who are on the science, technology, engineering, and math career track.
CONGRATULATIONS to employees at Evonik’s ROHACELL® plant in Mobile, Alabama, for achieving 10 years without a Lost Time Accident. #SafetyFirst is an important part of everyday culture at the production site of Performance Foams, makers of ROHACELL® PMI foam products. It takes daily teamwork and the employees are proud to be part of a winning team that has not had a Lost Time Accident in ten years. #SafetyAtEvonik #ResponsibleCare #HumanChemistry
